Abnormal individualized peak functional connectivity toward potential repetitive transcranial magnetic stimulation treatment of autism spectrum disorder

Functional connectivity (FC) derived from resting‐state functional magnetic resonance imaging has been widely applied to guide precise repetitive transcranial magnetic stimulation (rTMS). The left, right, and bilateral dorsolateral prefrontal cortices (DLPFC) have been used as rTMS treatment target regions for autism spectrum disorder (ASD), albeit with moderate efficacy. Thus, we aimed to develop an individualized localization method for rTMS treatment of ASD. We included 266 male ASDs and 297 male typically‐developed controls (TDCs) from the Autism Brain Imaging Data Exchange Dataset. The nucleus accumbens (NAc) was regarded as a promising effective region, which was used as a seed and individualized peak FC strength in the DLPFC was compared between ASD and TDC. Correlation analysis was conducted between individualized peak FC strength and symptoms in ASD. We also investigated the spatial distribution of individualized peak FC locations in the DLPFC and conducted voxel‐wise analysis to compare NAc‐based FC between the two groups. ASD showed stronger peak FC in the right DLPFC related to TDC (Cohen's d = −.19, 95% CI: −0.36 to −0.03, t = −2.30, p = .02). Moreover, negative correlation was found between the peak FC strength in the right DLPFC and Autism Diagnostic Observation Schedule (ADOS) scores, which assessed both the social communication and interaction (r = −.147, p = .04, uncorrected significant), and stereotyped behaviors and restricted interests (r = −.198, p = .02, corrected significant). Peak FC locations varied substantially across participants. No significant differences in NAc‐based FC in the DLPFC were found in the voxel‐wise comparison. Our study supports the use of individualized peak FC‐guided precise rTMS treatment of male ASD. Moreover, stimulating the right DLPFC might alleviate core symptoms of ASD.